Our results showed not only HOTAIRM1 was downregulated in CRC tissues, but also the circulating HOTAIRM1 levels were reduced in CRC patients, which might be considered as an independent biomarker of CRC. Here, HOTAIRM1 is linked to colorectal carcinoma.